TOP STORIES

• BUSINESS Sanofi Demands Payment of $416 Million from Novartis over Dissolved Equa Deal
  January 31, 2014

• BUSINESS Novartis Suspected of Drafting Letter of Consent for “Sign” Trial
  January 30, 2014

• BUSINESS Shionogi Influenza Campaign Causes Stir among Healthcare Professionals
  January 29, 2014

• ACADEMIA JCS’s 2013 Guidelines for Treatment of AF Recommend Dabigatran and Apixaban in Moderate-Risk Patients
  January 29, 2014

• REGULATORY MHLW Setting Out on Development of iPS Tech-Based Cardiotoxicity Evaluation
  January 28, 2014

• BUSINESS Ajinomoto to Downsize In-House Drug Discovery Research amid Slack Pharma Biz
  January 27, 2014

• BUSINESS Novartis Used Interim Report of “Sign” Trial in Tasigna Promotion, Set to Probe Its Involvement in Protocol Drafting
  January 24, 2014

• BUSINESS Novartis Adds LABA/LAMA Combination Ultibro to Lineup of Breezhaler Products for COPD Using the Same Inhaler
  January 24, 2014

• REGULATORY DPP-4 Inhibitors, Remicade to Face Market Expansion Re-Pricing in FY2014 Revision
  January 23, 2014

• BUSINESS Azilva Remains No.1 in December “Mind Share” Ranking in GP, HP Markets
  January 22, 2014

• BUSINESS Sales Reps Vied over Questionnaire Transfers in Tasigna Trial, Boss OK’ed Incentive Program: Novartis
  January 21, 2014

• BUSINESS Novartis Sales Reps Transferred Patient Questionnaires in Investigator-Led Trial
  January 20, 2014

• BUSINESS Japan’s First SGLT-2 Inhibitor Suglat Approved: Astellas
  January 20, 2014

• REGULATORY More Manpower, Knowledge Necessary for Giving New Drugs World’s First Approval: PMDA Chief Executive
  January 17, 2014

• REGULATORY Varicella, Adult Pneumococcal Vaccines to Join Japan’s Routine Immunization Program in October
  January 16, 2014

• ORGANIZATION Generic Makers Likely to Disclose Payments to Medical Institutions from Early May
  January 15, 2014

• ORGANIZATION JPWA Chair Weighs Cartel Deal to Unify Tax Display Methods after Sales Levy Hike
  January 14, 2014

• REGULATORY Did Novartis Employees “Willfully” Use Rigged Data in Diovan Ads? Statute of Limitations Will Pose Hurdles to Chase Key Figure
  January 10, 2014

• ORGANIZATION Next Drug Price Revision Won’t Help Promote Generic Use, JGA President Says
  January 9, 2014

• REGULATORY MHLW Files Criminal Complaint against Novartis over Diovan Ads
  January 9, 2014

ページ

• « 先頭
• ‹ Prev
• …
• 219
• 220
• 221
• 222
• 223
• 224
• 225
• 226
• 227
• …
• Next ›
• 最終 »